Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: A study protocol

Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: A study protocol

Although acute psychotic symptoms are often reduced by antipsychotic treatment, many patients with schizophrenia are impaired in daily functioning due to the persistence of negative and cognitive symptoms. Raloxifene, a Selective Estrogen Receptor Modulator (SERM) has been shown to be an effective a...

Full description

Bibliographic Details
Main Authors: Bodyl A. Brand, Janna N. de Boer, Sebastianus B.J. Oude Ophuis, Margot I.E. Slot, Bieke De Wilde, Kirsten C.E.E.R. Catthoor, Angelique J. Goverde, P. Roberto Bakker, Machteld C. Marcelis, Koen P. Grootens, Jurjen J. Luykx, Sophie M. Heringa, Cynthia Shannon Weickert, Iris E.C. Sommer, Thomas W. Weickert
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Contemporary Clinical Trials Communications
Subjects:
Antipsychotic medication
Estrogen
Raloxifene
Randomised controlled trial
Schizophrenia
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865420301654

Internet

http://www.sciencedirect.com/science/article/pii/S2451865420301654

Similar Items